Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

33.3%

1 terminated out of 3 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
P 1 (1)
P 2 (1)

Trial Status

Not Yet Recruiting1
Recruiting1
Terminated1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07418034Phase 2Not Yet Recruiting

A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)

NCT06747390Phase 1RecruitingPrimary

Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery

NCT01891695Not ApplicableTerminatedPrimary

OPSCC N0 Nodal Control With Reduced IMRT

Showing all 3 trials

Research Network

Activity Timeline